Grifols Shares Dip 0.69% as Market Stabilizes, 200‑Day MA Holds StrongGrifols shares dip 0.69%, staying near a 200‑day SMA as earnings guidance and regulatory approvals shape its double‑digit revenue outlook.GRIFOLS SASpain Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Samantha Roth 24/10/2026, 04:31 3 minutes to read
